Cargando…

Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination

Gardasil® (Merck) and Cervarix® (GlaxoSmithKline) both provide protection against infection with Human Papillomavirus 16 (HPV16) and Human Papillomavirus 18 (HPV18), that account for around 70% of cervical cancers. Both vaccines have been shown to induce high levels of neutralizing antibodies and ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Vicky, Jung, Wonyeong, Linde, Caitlyn, Coates, Emily, Ledgerwood, Julie, Costner, Pamela, Yamshchikov, Galina, Streeck, Hendrik, Juelg, Boris, Lauffenburger, Douglas A., Alter, Galit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017795/ https://www.ncbi.nlm.nih.gov/pubmed/36922512 http://dx.doi.org/10.1038/s41541-023-00628-8

Ejemplares similares

Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection
por: Zurek Munk-Madsen, Maria, et al.
Publicado: (2017)

Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix(®) or Gardasil(®) Vaccine
por: Godi, Anna, et al.
Publicado: (2015)

A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix(®) and Gardasil(®) Human Papillomavirus Vaccines in 12-15 Year Old Girls
por: Draper, Eve, et al.
Publicado: (2013)

Impact of HPV vaccination with Gardasil® in Switzerland
por: Jacot-Guillarmod, Martine, et al.
Publicado: (2017)

Efficacy of Human Papillomavirus L1 Protein Vaccines (Cervarix and Gardasil) in Reducing the Risk of Cervical Intraepithelial Neoplasia: A Meta-analysis
por: Haghshenas, Mohammad Reza, et al.
Publicado: (2017)

Update on Safety and Efficacy of HPV Vaccines: Focus on Gardasil
por: Soliman, Monica, et al.
Publicado: (2021)

HPV-Specific Systemic Antibody Responses and Memory B Cells are Independently Maintained up to 6 Years and in a Vaccine-Specific Manner Following Immunization with Cervarix and Gardasil in Adolescent and Young Adult Women in Vaccination Programs in Italy
por: Nicoli, Francesco, et al.
Publicado: (2020)

Cervarix(™): a vaccine for the prevention of HPV 16, 18-associated cervical cancer
por: Monie, Archana, et al.
Publicado: (2008)

Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity
por: Earnest, James T., et al.
Publicado: (2019)

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
por: Kaplonek, Paulina, et al.
Publicado: (2022)

HPV Type 6 and 18 Coinfection in a Case of Adult-Onset Laryngeal Papillomatosis: Immunization with Gardasil
por: Fancello, Virginia, et al.
Publicado: (2015)

Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
por: Bowman, Kathryn A., et al.
Publicado: (2022)

Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
por: Brown, Eric P., et al.
Publicado: (2017)

Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
por: Lofano, Giuseppe, et al.
Publicado: (2018)

A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX®) in female school students in Thailand
por: Jiamsiri, Suchada, et al.
Publicado: (2022)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
por: Richardson, Simone I., et al.
Publicado: (2018)

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
por: Loos, Carolin, et al.
Publicado: (2020)

Vector induced skewing of antibody Fc-effector functions
por: Chung, A, et al.
Publicado: (2012)

IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees
por: Fischinger, Stephanie, et al.
Publicado: (2020)

Cervical intraepithelial neoplasia grade 3 in a patient following Gardasil vaccination
por: McLucas, Bruce, et al.
Publicado: (2019)

Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination
por: Nduati, Eunice W., et al.
Publicado: (2021)

Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom
por: Van Effelterre, Thierry P, et al.
Publicado: (2015)

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
por: Boudreau, Carolyn M., et al.
Publicado: (2019)

Sex differences in vaccine-induced humoral immunity
por: Fischinger, Stephanie, et al.
Publicado: (2018)

A novel trivalent HPV 16/18/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model
por: Yin, Fei, et al.
Publicado: (2017)

Fc Receptor-Mediated Phagocytosis in Tissues as a Potent Mechanism for Preventive and Therapeutic HIV Vaccine Strategies
por: Sips, Magdalena, et al.
Publicado: (2016)

Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil™ in Adult Women
por: Luna, Joaquin, et al.
Publicado: (2013)

Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles
por: Kaplonek, Paulina, et al.
Publicado: (2021)

Mining for humoral correlates of HIV control and latent reservoir size
por: Das, Jishnu, et al.
Publicado: (2020)

A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis
por: Fischinger, Stephanie, et al.
Publicado: (2021)

Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors
por: Paquin-Proulx, Dominic, et al.
Publicado: (2021)

Incident HPV 51 Infection After Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard(®)
por: Halfon, Philippe, et al.
Publicado: (2010)

Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials
por: Fischinger, Stephanie, et al.
Publicado: (2021)

Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
por: Mackin, Samantha R., et al.
Publicado: (2022)

Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda
por: Kumakech, Edward, et al.
Publicado: (2016)

Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis
por: Lu, Lenette L, et al.
Publicado: (2020)

Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography
por: Fox, Julie M., et al.
Publicado: (2023)

Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions
por: Shiakolas, Andrea R., et al.
Publicado: (2021)

Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Cross-neutralizing antibodies elicited by the Cervarix(®) human papillomavirus vaccine display a range of Alpha-9 inter-type specificities()
por: Bissett, Sara L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3ovrmkej6dtofoj91atugejdoq